Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €237.24 EUR
Change Today +0.165 / 0.07%
Volume 0.0
PY2 On Other Exchanges
As of 7:10 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mahkam Zanganeh D.D.S., MBA

Chief Operating Officer, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Mahkam Zanganeh, also known as Maky, D.D.S., MBA has been the Chief Operating Officer of Pharmacyclics Inc. since August 1, 2012. Dr. Zanganeh served as Chief of Staff at Pharmacyclics Inc. from December 2010 to August 1, 2012 and served as its Chief Business Officer. She served as Vice President of Business Development at Pharmacyclics Inc. since August 2008. Dr. Zanganeh served as Vice President of Marketing of Pharmacyclics Inc. since August 2008. From September ...

Read Full Background

Corporate Headquarters*

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships*

There is no Board Members Memberships data available.


Schiller International University
Unknown/Other Education
Université de Strasbourg

Other Affiliations*

Annual Compensation*

Total Annual Compensation$893,209

Stock Options*

All Other Compensation$5,160
Exercised Options42,482
Exercised Options Value$5,439,911
Exercisable Options493,122
Unexercisable Options46,563
Total Value of Options$5,439,911
Total Number of Options679,770

Total Compensation*

Total Annual Cash Compensation$898,369
Total Short Term Compensation$893,209
Other Long Term Compensation$5,160
Total Calculated Compensation$6,337,160
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PY2:GR €237.24 EUR +0.165


Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at